Half-year report · Q2
2689.TEDINET S100V7MJ
Period2024-07-01 → 2024-12-31
Filed2025-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥60.6bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥118.6bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥57.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥808m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥747m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥824m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥746m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥816m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥745m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥46.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥43.2bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥43.4bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.3bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥31.9bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥11.5bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.2bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥800m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥146m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥889m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥673m | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥347m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥109.44 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥251.68 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.01 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 24.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥67m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥19,000 |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥105m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥57.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥56.5bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥816m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥715m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥64m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥60.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥880m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥875m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥76m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥1m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥102m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥53.6bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥656m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥669m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥68m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥58.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥57.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥725m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥823m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 522
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | Prior1YTDDuration | 745437000 | JPY |
| Income before income taxes | CurrentYTDDuration | 815698000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 259008000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 289133000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 2555000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 3832000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | － | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 11132000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 3097000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -1977000 | JPY |
| Increase decrease in net defined benefit asset ope cf | Prior1YTDDuration | -15370000 | JPY |
| Increase decrease in net defined benefit asset ope cf | CurrentYTDDuration | -29899000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 27894000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 19485000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | CurrentYTDDuration | 1226000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | Prior1YTDDuration | 25318000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | CurrentYTDDuration | 24167000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -2175000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -1730000 | JPY |
| Compensation income ope cf | Prior1YTDDuration | － | JPY |
| Compensation income ope cf | CurrentYTDDuration | -5000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 9798000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 16189000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | － | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -15349000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1YTDDuration | -49000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | CurrentYTDDuration | -461000 | JPY |
| Loss on retirement of property plant and equipment ope cf | Prior1YTDDuration | 751000 | JPY |
| Loss on retirement of property plant and equipment ope cf | CurrentYTDDuration | 2896000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -1629705000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -1711736000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -429463000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -1147550000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 1474415000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 2216345000 | JPY |
| Increase decrease in long term accounts payable other ope cf | Prior1YTDDuration | -27077000 | JPY |
| Increase decrease in long term accounts payable other ope cf | CurrentYTDDuration | － | JPY |
| Other net ope cf | Prior1YTDDuration | -91218000 | JPY |
| Other net ope cf | CurrentYTDDuration | -588153000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 353216000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -101752000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1936000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 1730000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -10908000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -16945000 | JPY |
| Proceeds from compensation ope cf | Prior1YTDDuration | － | JPY |
| Proceeds from compensation ope cf | CurrentYTDDuration | 5000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -537078000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -687640000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |